Advertisement

Jump to content


Photo

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 With Moderate to Severe Crohn's


  • Please log in to reply
No replies to this topic

#1 Jeffrey Roberts

Jeffrey Roberts

    Member #1 Founder

  • Founder
  • PipPipPipPip
  • 7,075 posts

  • IBS Penpal
  • Country:United States

Posted 28 January 2011 - 11:01 AM

Advertisement
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's DiseaseDetails: The study will examine the safety and effectiveness of AMG 827 for the treatment of moderate to severe Crohn's disease. Patients will randomly receive either AMG 827 or placebo (a lookalike liquid that doesn't have any drug in it) and neither the doctor nor the patient will know what treatment is being given.Ages Eligible for Study: 18-65 years of ageGenders Eligible for Study: Male and femalesContact Information: http://www.amgencrohnsdiseasestudy.com or http://clinicaltrial...how/NCT01150890 or call 1-866-57AMGEN (1-866-572-6436)Principal investigator: Multiple investigators


Advertisement




Advertisement


About Us | Contact Us | Advertise With Us | Disclaimer | Terms of Service | Crisis Resources

Irritable Bowel Syndrome |  Inflammatory Bowel Disease |  Crohn's Disease |  Ulcerative Colitis |  Fibromyalgia |  GERD - Reflux Disease


©Copyright 1995-2014 IBS Self Help and Support Group All rights reserved




This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here